Specialized Eye Diseases Hospital For Active Treatment-Varna EOOD

The medical center is at the forefront of ophthalmology research, focusing on innovative treatments for neovascular age-related macular degeneration (nAMD). This condition, a leading cause of vision loss, is being addressed through comparative studies of new therapeutic agents like RBS-001 against established treatments such as Eylea®.

• Neovascular Age-Related Macular Degeneration (nAMD)
• Comparative Efficacy Studies
• Visual Acuity Improvement

By exploring the equivalence in efficacy and safety of novel treatments, the center contributes significantly to enhancing patient outcomes and expanding therapeutic options in the field of ophthalmology.

Specializing in pediatric ophthalmology, the center conducts extensive research on retinopathy of prematurity (ROP), a critical condition affecting premature infants. Through long-term outcome studies, the center evaluates the effectiveness and safety of treatments administered in early life stages.

• Retinopathy of Prematurity (ROP)
• Long-Term Safety and Efficacy
• Binocular Visual Acuity

These studies are pivotal in understanding the developmental impacts of early interventions and in guiding future treatment protocols to ensure optimal visual health in pediatric populations.